This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Rigel Pharmaceuticals, Incorporated. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Innovator Spotlight: Chrystelle Lamagna
Introduction
Chrystelle Lamagna is a prominent inventor based in South San Francisco, CA. She has made significant contributions to the field of biotechnology, particularly in the development of kinase inhibitors. Her innovative work has the potential to impact the treatment of various diseases.
Latest Patents
Chrystelle holds a patent for "Tricyclic IRAK inhibitors." This patent discloses compounds that are useful as kinase inhibitors, specifically targeting interleukin receptor associated kinases (IRAK). The disclosed compounds and compositions may be utilized to treat or prevent kinase-associated diseases, particularly those associated with IRAK.
Career Highlights
Chrystelle is currently associated with Rigel Pharmaceuticals, Incorporated, where she continues to advance her research and development efforts. Her work at Rigel Pharmaceuticals focuses on creating innovative solutions for complex medical challenges.
Conclusion
Chrystelle Lamagna's contributions to the field of biotechnology exemplify the impact of innovative thinking in medicine. Her work on IRAK inhibitors showcases her commitment to improving health outcomes through scientific advancement.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile